Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients
- PMID: 16477632
- DOI: 10.1002/ijc.21798
Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients
Abstract
Germline mutations in fumarate hydratase (FH) gene at 1q43 predispose to hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. In HLRCC, the most common clinical features are leiomyomas of the skin and uterus, and in a subset of the families, renal cell cancer (RCC) and uterine leiomyosarcoma (ULMS) occur frequently at young age. This study was conducted to evaluate the possible contribution of FH mutations in a population-based series of early onset (< or = 45 years) ULMSs. Eighty-one cases were identified through the national cancer registry, and samples from 67 cases (83%) were available for FH mutation screening and analysis of allelic imbalance (AI) at the FH locus. Seventeen percent of tumors showed AI. In the mutation analysis, a novel missense mutation K424R was found. The mutation was also found from the patient's normal tissue. To study whether this variant has functional consequences, FH enzyme activity assay was performed in a cell model. The activity of the mutated protein was significantly reduced as compared to wild type (p = 0.009). This study shows that FH germline mutations can occur in seemingly nonsyndromic cases of ULMS (1/67, 1.5%). It appears that on the population level hereditary FH defects do play a role in pathogenesis of sporadic early onset ULMSs, albeit rarely.
2006 Wiley-Liss, Inc.
Similar articles
-
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.Am J Pathol. 2004 Jan;164(1):17-22. doi: 10.1016/S0002-9440(10)63091-X. Am J Pathol. 2004. PMID: 14695314 Free PMC article.
-
Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.Clin Genet. 2011 Jan;79(1):49-59. doi: 10.1111/j.1399-0004.2010.01486.x. Clin Genet. 2011. PMID: 20618355
-
No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.Cancer Lett. 2006 Apr 8;235(1):136-40. doi: 10.1016/j.canlet.2005.04.017. Epub 2005 Jun 8. Cancer Lett. 2006. PMID: 15949892
-
Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.Br J Dermatol. 2005 Jul;153(1):11-7. doi: 10.1111/j.1365-2133.2005.06678.x. Br J Dermatol. 2005. PMID: 16029320 Review.
-
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R7-13. doi: 10.1093/hmg/ddm043. Hum Mol Genet. 2007. PMID: 17613550 Review.
Cited by
-
Recent advances in understanding and managing leiomyosarcomas.F1000Prime Rep. 2015 May 12;7:55. doi: 10.12703/P7-55. eCollection 2015. F1000Prime Rep. 2015. PMID: 26097728 Free PMC article. Review.
-
Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.Int J Mol Sci. 2019 Aug 5;20(15):3825. doi: 10.3390/ijms20153825. Int J Mol Sci. 2019. PMID: 31387281 Free PMC article. Review.
-
Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids.Case Rep Womens Health. 2017 Jun 23;15:31-34. doi: 10.1016/j.crwh.2017.06.004. eCollection 2017 Jul. Case Rep Womens Health. 2017. PMID: 29593997 Free PMC article.
-
Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome.Fam Cancer. 2012 Mar;11(1):115-21. doi: 10.1007/s10689-011-9485-3. Fam Cancer. 2012. PMID: 22127509
-
Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.Oncologist. 2016 Aug;21(8):1002-13. doi: 10.1634/theoncologist.2016-0079. Epub 2016 Jul 8. Oncologist. 2016. PMID: 27401891 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous